Cargando…

Inhibition by Fibrin Coagulation of Lung Cancer Cell Destruction by Human Interleukin‐2‐activated Killer Cells

We examined the effect of fibrin coagulation on tumor cytotoxicity mediated by human lymphokine (IL‐2)‐activated killer (LAK) cells. LAK cells were induced from peripheral blood mononuclear cells (MNC) by culture with recombinant IL‐2 for 4 or 5 days, and LAK cell‐mediated cytotoxicity against tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atagi, Shinji, Sone, Saburo, Fukuta, Katsuyuki, Ogura, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918668/ https://www.ncbi.nlm.nih.gov/pubmed/1452461 http://dx.doi.org/10.1111/j.1349-7006.1992.tb02726.x

Ejemplares similares

Enhancement of Therapeutic Effect of Interleukin‐2 on Spontaneous Pulmonary Metastases of Lewis Lung Carcinoma by Killer Helper Factor Associated with Increased Induction of Killer Activity
por: Fukuta, Katsuyuki, et al.
Publicado: (1989)

Interleukin‐2‐inducible Killer Activity and Its Regulation by Blood Monocytes from Autologous Lymphocytes of Lung Cancer Patients
por: Sone, Saburo, et al.
Publicado: (1991)

Human Alveolar Macrophages Augment Natural Killer Cell Stimulatory Factor (Interleukin‐12)‐inducible Killer Activity from Autologous Blood Lymphocytes
por: Haku, Takashi, et al.
Publicado: (1995)

Lymphokine‐activated Killer Induction and Its Regulation by Macrophages in Malignant Pleural Effusions
por: Yanagawa, Hiroaki, et al.
Publicado: (1989)

Induction Mechanism of Human Blood CD8(+) T Cell Proliferation and Cytotoxicity by Natural Killer Cell Stimulatory Factor (Interleukin‐12)
por: Nabioullin, Roustem, et al.
Publicado: (1994)

Induction by Interleukin‐15 of Human Killer Cell Activity against Lung Cancer Cell Lines and Its Regulatory Mechanisms
por: Takeuchi, Eiji, et al.
Publicado: (1996)

Suppression by Interleukin 4 of Activation of Human Blood Monocytes to the Tumoricidal State
por: Nishioka, Yasuhiko, et al.
Publicado: (1990)

Granulocyte‐Macrophage Colony‐stimulating Factor Augments Lymphokine‐activated Killer Activity from Pleural Cavity Mononuclear Cells of Lung Cancer Patients without Malignant Effusion
por: Takahashi, Keiji, et al.
Publicado: (1995)

Killing of Alveolar Macrophages and of Monocytes that Have Responded to Granulocyte‐Macrophage Colony‐stimulating Factor by Human Lymphokine‐activated Killer Cells
por: Sone, Saburo, et al.
Publicado: (1989)

Autonomous Expressions of Cytokine Genes by Human Lung Cancer Cells and Their Paracrine Regulation
por: Mizuno, Kazuto, et al.
Publicado: (1994)

Enhancement by Monocytes of Perform Production and Its Gene Expression by Human CD8+ T Cells Stimulated with Interleukin‐2
por: Sugihara, Kohji, et al.
Publicado: (1992)

Production of Tumor Necrosis Factor‐α by Alveolar Macrophages of Lung Cancer Patients
por: Okubo, Akio, et al.
Publicado: (1990)

Comparative analysis of interleukin 15 and interleukin 2 for induction of killer activity and of type 2 cytokine production by mononuclear cells from lung cancer patients.
por: Takeuchi, E., et al.
Publicado: (1998)

Monoclonal Anti‐P‐glycoprotein Antibody‐dependent Killing of Multidrug‐resistant Tumor Cells by Human Mononuclear Cells
por: Heike, Yuji, et al.
Publicado: (1990)

Potential Value of Cetylmannoside‐modified Liposomes as Carriers of Macrophage Activators to Human Blood Monocytes
por: Yamashita, Chikamasa, et al.
Publicado: (1991)

Effector Cell Analysis of Human Multidrug‐resistant Cell Killing by Mouse‐Human Chimeric Antibody against P‐Glycoprotein
por: Nishioka, Yasuhiko, et al.
Publicado: (1992)

Cyclosporin A Enhances Susceptibility of Multi‐drug Resistant Human Cancer Cells to Anti‐P‐glycoprotein Antibody‐dependent Cytotoxicity of Monocytes, but Not of Lymphocytes
por: Yano, Seiji, et al.
Publicado: (1994)

Serum levels of interleukin 6 in patients with lung cancer.
por: Yanagawa, H., et al.
Publicado: (1995)

Combination Therapy with Antibody and Interleukin–2 Gene Transfer against Multidrug–resistant Cancer Cells
por: Shinohara, Tsutomu, et al.
Publicado: (1997)

Enhancement of blood coagulation by soluble fibrin complexes
Publicado: (1975)

Anemia: Fibrin Coagulates Only under the Influence of Coagulating Substance, Termed Globulin
por: Wooster, David
Publicado: (1866)

Integrating platelet and coagulation activation in fibrin clot formation
por: Swieringa, Frauke, et al.
Publicado: (2018)

Interleukin‐37 inhibits osteoclastogenesis and alleviates inflammatory bone destruction
por: Tang, Ruohui, et al.
Publicado: (2018)

How natural killer cells avoid self-destruction when killing their targets
por: Wurzer, Hannah, et al.
Publicado: (2021)

Evaluation of the Diagnostic Performance of Fibrin Monomer in Disseminated Intravascular Coagulation
por: Park, Kyoung-Jin, et al.
Publicado: (2011)

Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets
por: Goeijenbier, Marco, et al.
Publicado: (2014)

A New Quinoline Derivative MS‐209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P‐glycoprotein‐expressing Human Small Cell Lung Cancer Cells
por: Nokihara, Hiroshi, et al.
Publicado: (2001)

STUDIES ON BLOOD COAGULATION : II. THE FORMATION OF FIBRIN FROM THROMBIN AND FIBRINOGEN
por: Eagle, Harry
Publicado: (1935)

The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.
por: Kogure, Toshiaki, et al.
Publicado: (2002)

Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury
por: Yu, Yunhong, et al.
Publicado: (2021)

Memory-like Liver Natural Killer Cells are Responsible for Islet Destruction in Secondary Islet Transplantation
por: Saeki, Y., et al.
Publicado: (2019)

Anti‐ganglioside GM(2) Monoclonal Antibody‐dependent Killing of Human Lung Cancer Cells by Lymphocytes and Monocytes
por: Hanibuchi, Masaki, et al.
Publicado: (1996)

Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia–lymphoma and peripheral T-cell lymphoma
por: Ogura, Michinori, et al.
Publicado: (2016)

Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective
por: Risser, Fanny, et al.
Publicado: (2022)

Inhibition of natural killer (nk) cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome
por: Cifaldi, Loredana, et al.
Publicado: (2014)

Oligonucleotide Sequences Required for Natural Killer Cell Activation
por: Kuramoto, Etsuro, et al.
Publicado: (1992)

Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells
Publicado: (1996)

Transbronchial lung cryobiopsy in idiopathic acute fibrinous and organizing pneumonia
por: Shintani, Ryota, et al.
Publicado: (2019)

Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice
Publicado: (1989)

Natural Killer Cells in the Lungs
por: Cong, Jingjing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1u771bos6la4t8ldhobqif9t1g